
#### NACHC.A1 HIV

|Data Element Id|Data Element|
|---|---|
||[HIV infection as a condition](StructureDefinition-nachc-a1-de1.html)|

#### NACHC.A2 HIV test

|Data Element Id|Data Element|
|---|---|
||[HIV-1 HIV 2 Ab Ag tests](StructureDefinition-nachc-a2-de1.html)|
||[HIV Viral Load](StructureDefinition-nachc-a2-de172.html)|

#### NACHC.B1 HCV

|Data Element Id|Data Element|
|---|---|
||[Hepatitis C Virus Infection (Disorders)](StructureDefinition-nachc-b1-de1.html)|
||[Chronic Infection of liver due to Hepatitis C virus](StructureDefinition-nachc-b1-de31.html)|
||[HCV Infection (Organism or Substance in Lab Results)](StructureDefinition-nachc-b1-de34.html)|
||[Hepatitis C condition](StructureDefinition-nachc-b1-de65.html)|

#### NACHC.B2 HCV test

|Data Element Id|Data Element|
|---|---|
||[Hepatitis C Ag](StructureDefinition-nachc-b2-de1.html)|
||[Hepatitis C nucleic acid](StructureDefinition-nachc-b2-de4.html)|
||[Hepatitis C virus antibody test using Immunoblotting (IB) method](StructureDefinition-nachc-b2-de40.html)|
||[Hepatitis C virus antibody test](StructureDefinition-nachc-b2-de60.html)|
||[Hepatitis C virus nucleic (RNA) test](StructureDefinition-nachc-b2-de80.html)|

#### NACHC.C1 Syphilis

|Data Element Id|Data Element|
|---|---|
||[Syphilis](StructureDefinition-nachc-c1-de1.html)|
||[Syphilis (Organism or Substance in Lab Results)](StructureDefinition-nachc-c1-de184.html)|
||[Syphilis condition](StructureDefinition-nachc-c1-de191.html)|

#### NACHC.C2 Syphilis test

|Data Element Id|Data Element|
|---|---|
||[Syphilis (Tests for Treponema pallidum Nucleic Acid)](StructureDefinition-nachc-c2-de1.html)|
||[Syphilis (Tests for Treponemal or Non Treponemal Antibody)](StructureDefinition-nachc-c2-de7.html)|

#### NACHC.D1 Gonorrhea

|Data Element Id|Data Element|
|---|---|
||[Gonococcal Infections and Venereal Diseases](StructureDefinition-nachc-d1-de1.html)|
||[Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)](StructureDefinition-nachc-d1-de184.html)|
||[Gonorrhea [Neisseria species Unspecified] (Organism or Substance in Lab Results)](StructureDefinition-nachc-d1-de196.html)|
||[Gonorrhea [Secondary Sites Complications Chronic] (Disorders)](StructureDefinition-nachc-d1-de201.html)|

#### NACHC.D2 Gonorrhea test

|Data Element Id|Data Element|
|---|---|
||[Gonorrhea Tests for Neisseria gonorrhea by Culture](StructureDefinition-nachc-d2-de1.html)|
||[Gonorrhea Tests and Chlamydia/Gonorrhea Combined Tests](StructureDefinition-nachc-d2-de100.html)|
||[Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)](StructureDefinition-nachc-d2-de16.html)|
||[Gonorrhea (Tests for Neisseria species by Culture and Identification Method)](StructureDefinition-nachc-d2-de59.html)|
||[Gonorrhea test](StructureDefinition-nachc-d2-de66.html)|

#### NACHC.E1 Chlamydia

|Data Element Id|Data Element|
|---|---|
||[Chlamydia](StructureDefinition-nachc-e1-de1.html)|
||[Chlamydia Infections and Venereal Diseases](StructureDefinition-nachc-e1-de26.html)|
||[Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders)](StructureDefinition-nachc-e1-de31.html)|
||[Chlamydia trachomatis organism or Chlamydia trachomatis substance](StructureDefinition-nachc-e1-de62.html)|

#### NACHC.E2 Chlamydia test

|Data Element Id|Data Element|
|---|---|
||[Chlamydia Screening](StructureDefinition-nachc-e2-de1.html)|
||[Chlamydia Trachomatis Tests, FPAR](StructureDefinition-nachc-e2-de122.html)|
||[Tests for Chlamydia trachomatis Antigen](StructureDefinition-nachc-e2-de124.html)|
||[Tests for Chlamydia trachomatis by Culture and Identification Method)](StructureDefinition-nachc-e2-de153.html)|
||[Tests for Chlamydia trachomatis Nucleic Acid](StructureDefinition-nachc-e2-de163.html)|
||[Chlamydia test](StructureDefinition-nachc-e2-de48.html)|

#### NACHC.F1 Injection Drug Use

|Data Element Id|Data Element|
|---|---|
||[Drug Rehabilitation](StructureDefinition-nachc-f1-de1.html)|
||[Injection Findings](StructureDefinition-nachc-f1-de12.html)|
||[IDU as a condition](StructureDefinition-nachc-f1-de15.html)|
||[Injection Drug Use](StructureDefinition-nachc-f1-de200.html)|

#### NACHC.F2 Pregnancy

|Data Element Id|Data Element|
|---|---|
||[Pregnancy Encounters](StructureDefinition-nachc-f2-de1.html)|
||[Maternal Care](StructureDefinition-nachc-f2-de104.html)|
||[Pregnancy Conditions](StructureDefinition-nachc-f2-de1128.html)|
||[Pregnancy Supervision](StructureDefinition-nachc-f2-de38.html)|
||[Pregnancy Procedures](StructureDefinition-nachc-f2-de668.html)|
||[Pregnancy Observations](StructureDefinition-nachc-f2-de900.html)|

#### NACHC.F3 Post Exposure Prophylaxis

|Data Element Id|Data Element|
|---|---|
||[Post Exposure Prophylaxis](StructureDefinition-nachc-f3-de1.html)|
